1. Home
  2. MRK vs MS Comparison

MRK vs MS Comparison

Compare MRK & MS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

HOLD

Current Price

$115.81

Market Cap

268.7B

Sector

Health Care

ML Signal

HOLD

Logo Morgan Stanley

MS

Morgan Stanley

HOLD

Current Price

$166.29

Market Cap

255.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRK
MS
Founded
2000
1924
Country
United States
United States
Employees
N/A
83000
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
268.7B
255.2B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
MRK
MS
Price
$115.81
$166.29
Analyst Decision
Buy
Buy
Analyst Count
14
14
Target Price
$124.64
$177.42
AVG Volume (30 Days)
7.3M
6.2M
Earning Date
04-23-2026
04-15-2026
Dividend Yield
2.98%
2.48%
EPS Growth
8.01
N/A
EPS
7.28
N/A
Revenue
$65,011,000,000.00
N/A
Revenue This Year
$3.74
$12.04
Revenue Next Year
$5.47
$5.39
P/E Ratio
$15.61
$17.30
Revenue Growth
1.31
N/A
52 Week Low
$75.40
$94.33
52 Week High
$125.14
$192.68

Technical Indicators

Market Signals
Indicator
MRK
MS
Relative Strength Index (RSI) 47.54 51.48
Support Level $113.82 $154.82
Resistance Level $125.14 $171.77
Average True Range (ATR) 2.44 4.26
MACD -0.62 0.89
Stochastic Oscillator 37.36 80.55

Price Performance

Historical Comparison
MRK
MS

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

About MS Morgan Stanley

Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 82,000 employees as of year-end 2025. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $9.3 trillion in client assets at the end of its most recent fiscal year. After reincorporation as a bank holding company in the wake of the global financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with more than $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.

Share on Social Networks: